Nutritional one-two punch may slow retinitis pigmentosa

Article

A recent analysis of three clinical trials has provided further evidence that a supplement of pure vitamin A combined with an omega-3 rich fatty acid diet can slow vision loss in adults with the common forms of retinitis pigmentosa.

"It does not prevent, cure, or reverse the disease," cautioned Jeff Anshel, OD, FAAO, president of the Ocular Nutrition Society. "It just slows the progression." But with a disease that has no other effective treatments, the positive study data can be seen as a glass half full. "Anything that keeps people with their vision longer is a good thing," he said.

Eliot Berson, MD, and colleagues of Harvard Medical School and the Massachusetts Eye and Ear Infirmary reported that RP patients who take a high dose of vitamin A pal-mitate and consume a diet rich in omega-3 lost an average of 0.59 letters of visual acuity per year. Those taking similar amounts of vitamin A palmitate but consuming lower amounts of omega-3s lost an average of 1.0 letter per year, as measured by Early Treatment or Diabetic Retinopathy Study (EDTRS) distance acuity. The paper was published in the February issue of Archives of Ophthalmology. [Arch Ophthalmol. Published online 13 Feb 2012)

He also noted that the analysis found only vitamin A palmitate, not other forms vitamin A, was effective in postponing vision loss in RP. "Beta-carotene or carrots are not a suitable substitute for vitamin A palmitate in the context of this treatment," Dr. Berson said.

Analyzing data from a total of 357 patients from three clinical trials, each lasting between 4 and 6 years, Dr. Berson and colleagues found that daily doses of 15,000 IU of oral vitamin A palmitate in combination with eating at least 0.2 gram of omega-3 fatty acids daily-the equivalent of one to two 3-ounce servings of oily fish per week-slowed the rate of decline in retinal function.

Recent Videos
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Bonnie An Henderson in an interview for the EnVision Summit
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
EnVision Summit cofounder and program chair Dr Bonnie Henderson chats about collaborative eye care
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Bonnie An Henderson in an interview for the EnVision Summit
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
© 2025 MJH Life Sciences

All rights reserved.